We are the largest nonprofit dedicated to creating a world without blood cancers. Since 1949, we’ve invested more than $1.6 billion in groundbreaking research, pioneering many of today’s most innovative approaches.
We’re a company that takes on the toughest health challenges. But we do more than treat diseases—we aim to make a remarkable impact on people’s lives.
The NHLBI is the nation’s leader in the prevention and treatment of heart, lung, blood and sleep disorders.
In partnership with community, business, and government leaders we pursue our mission: to advance some of society’s most calcified systems, creating pathways to genuine opportunity so people from all communities can achieve their full potential.
Develop new medical strategies for the prevention, diagnosis, treatment and cure of human diseases, injuries and conditions through human stem cells.
The purpose of Gabrielle’s Angel Foundation for Cancer Research is to encourage the development of more effective therapies for patients with leukemia, lymphoma and related cancers.
EvansMDS, the primary medical funding initiative of the Edward P. Evans Foundation, is dedicated to finding cures for Myelodysplastic Syndromes (MDS)—a collection of rare but devastating types of blood cancer.